Log In Sign Up Premium
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘Lilly Eli & Co (LLY)’

The Pharmaceutical Industry’s 10 Biggest R&D Budgets

Innovation is everything when it comes to the pharmaceutical sector.

Keep Reading →

September 23 - News - Comments

Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)’s Stifel Conference Presentation

There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ:KERX) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston.

Keep Reading →

September 15 - News - Comments

Celgene Corporation (CELG), Bristol-Myers Squibb Co (BMY): One Drug Dramatically Reshaping Pancreatic Cancer Treatment

A couple months may not seem like a long time, but when you're diagnosed with pancreatic cancer, the prospect of a few months makes a huge difference.

Keep Reading →

September 13 - Dividend Stocks, News - Comments

MannKind Corporation (MNKD), Seattle Genetics, Inc. (SGEN), Eli Lilly & Co. (LLY): A Pharmacology Primer for Biotech Investors

In pharmacology, we don't only have to consider the actions of the drug on the body.

Keep Reading →

September 12 - News - Comments

NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY), Alexion Pharmaceuticals, Inc. (ALXN): Three Justifications for the High Cost of Gattex

NPS Pharmaceuticals, Inc.

Keep Reading →

September 11 - News - Comments

Express Scripts Holding Company (ESRX), Novo Nordisk A/S (ADR) (NVO), Walgreen Company (WAG): Don’t Mess With This 800-Pound Gorilla in the Pharma Space

Express Scripts Holding Company (NASDAQ:ESRX)  -- the largest pharmacy benefit manager, or PBM, in America -- is also one of the most important companies in the health care ...

Keep Reading →

September 11 - News - Comments

Pfizer Inc. (PFE), Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Two Lucrative Drug Markets You Should Avoid

You really don't need both. There are enough people with rheumatoid arthritis or high cholesterol, for example, to have multiple blockbuster drugs that treat the diseases.

Keep Reading →

September 3 - News - Comments

Eli Lilly & Co. (LLY), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Where We’re Headed

Over the past couple of months we've discussed many of the biggest risk factors associated with some of the leading causes of death in the United States -- heart disease, cancer...

Keep Reading →

September 3 - News - Comments

Will This Destroy MannKind Corporation (MNKD)?

The drug more closely mimics how the body secretes insulin after a meal to lower blood sugar, doing its job and leaving the bloodstream quickly.

Keep Reading →

September 2 - News - Comments

Tyson Foods, Inc. (TSN), Merck & Co., Inc. (MRK): Food Companies Suspend Growth Meds for Animals

Top beef producer Tyson Foods, Inc. (NYSE:TSN) has decided to stop buying cattle that are fed the growth additive Zilmax, produced by Merck & Co., Inc. (NYSE:MRK).

Keep Reading →

August 29 - News - Comments

MannKind Corporation (MNKD): To Infinity And Beyond?

The idea inspired me to issue my own questions about the company, using the questions as a crutch to explain my position.

Keep Reading →

August 28 - News - Comments

Pfizer Inc. (PFE): The Procter & Gamble Company (PG)’s Fall Can’t Stop the Dow Jones Industrial Average (.DJI)’s Bounce

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing...

Keep Reading →

August 28 - News - Comments

Eli Lilly & Co. (LLY), Novartis AG (ADR) (NVS), Shire PLC (ADR) (SHPG): A Closer Look at the Controversial Market Growth of ADHD Treatments

The existence of ADHD, or attention deficit hyperactivity disorder, has been a hot-button topic since the 1970s.

Keep Reading →

August 28 - News - Comments

Roche Holding Ltd. (ADR) (RHHBY), Eli Lilly & Co. (LLY): Understanding the Massive Market Potential of Monoclonal Antibodies

Over the past several years, monoclonal antibodies have revolutionized cancer treatments.

Keep Reading →

August 28 - News - Comments

Tyson Foods, Inc. (TSN), Smithfield Foods, Inc. (SFD): Merck & Co., Inc. (MRK) Buried by Industry Beef

Like a pebble rolling downhill and starting an avalanche, the decision by Tyson Foods, Inc.

Keep Reading →

August 28 - News - Comments

Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): Positive News for This Troubled Pharma Player

Eli Lilly & Co. (NYSE:LLY) recently rose nearly 3% following positive phase 3 results for cancer drug necitumumab.

Keep Reading →

August 27 - News - Comments

Alkermes Plc (ALKS), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN): Tackling Pain and Addiction

Alkermes Plc (NASDAQ:ALKS) is primarily known for its schizophrenia and multiple sclerosis drug treatments.

Keep Reading →

August 26 - News - Comments

Peregrine Pharmaceuticals (PPHM), Sanofi SA (ADR) (SNY): Is This Experimental Lung Cancer Drug Back on Track?

Peregrine Pharmaceuticals (NASDAQ:PPHM), a developmental stage biotech focusing on oncology treatments, recently announced that its lead drug candidate, bavituximab, was heading...

Keep Reading →

August 23 - News - Comments

Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Forest Laboratories, Inc. (FRX): The Past, Present, and Future of Alzheimer’s Treatments

Editor’s Note: A previous version of this post incorrectly stated that Eli Lilly’s experimental drug solanezumab is a BACE inhibitor.

Keep Reading →

August 23 - News - Comments

Eli Lilly & Co. (LLY): Is It Destined for Greatness?

Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.

Keep Reading →

August 22 - News - Comments

Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does Incyte Corporation (INCY) Deserve Its New Valuation?

One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK inhibitors.

Keep Reading →

August 22 - News - Comments

Valeant Pharmaceuticals Intl Inc (VRX), GlaxoSmithKline plc (ADR) (GSK) – CAPScall of the Week: Raptor Pharmaceutical Corp. (RPTP)

For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.

Keep Reading →

August 20 - News - Comments

AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD): Three New Diabetes Drugs Possibly on the Way Soon

It's no wonder that plenty of companies are developing diabetes drugs. There are more than 370 million people with diabetes worldwide.

Keep Reading →

August 20 - News - Comments

MannKind Corporation (MNKD), Eli Lilly & Co. (LLY): The Easiest Prediction in Biotech This Summer

Nothing is for certain in biotech, but it looks to me like the extended phase 3 program has an extremely high likelihood of coming up positive.

Keep Reading →

August 12 - News - Comments

MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): A Good Drug That’s Too Risky to Buy

In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)'s extended phase 3 program for its inhaled insulin, Afrezza, is likely to produce ...

Keep Reading →

August 12 - News - Comments

Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Allergan, Inc. (AGN): Three Companies Working to Make Your Migraines Milder

The National Headache Foundation (yes, there is such an organization) says that around 30 million Americans suffer from migraines.

Keep Reading →

August 6 - News - Comments

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Will Zoetis Earnings Deliver on Post-Spinoff Growth?

Zoetis will release its quarterly report on Tuesday, and investors will get their first look at the company as a completely independent business entity.

Keep Reading →

August 5 - News - Comments

Eli Lilly & Co. (LLY), Novartis AG (ADR) (NVS): Is This Company Getting Ahead of Itself?

The biotechnology industry is one of the riskiest places to put your money. However, when companies get everything right, the fortunes made there are usually massive.

Keep Reading →

August 5 - News - Comments

Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Bristol-Myers Squibb Co (BMY): These Pharmaceutical Giants Are Teetering Dangerously Near The Patent Cliff

In the hunt for sustainable dividend yields, investors have rushed into the stocks of major pharmaceutical companies.

Keep Reading →

August 3 - News - Comments

Incyte Corporation (INCY) Earnings Cruise on Jakafi Growth

Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings on Wednesday.

Keep Reading →

August 1 - News - Comments

Intel Corporation (INTC), Chevron Corporation (CVX), Eli Lilly & Co. (LLY): What You Need to Know About Dividends

When it comes to stock investing, conventional thinking dictates that returns are all about capital appreciation.

Keep Reading →

August 1 - News - Comments

Is More Patent Pain Headed Merck & Co., Inc. (MRK)’s Way?

Merck & Co., Inc. (NYSE:MRK) might be one of big pharma's largest companies, but this health care leader has had a tough go recently.

Keep Reading →

July 31 - News - Comments

Three Things You Need to Know From Merck & Co., Inc. (MRK)’s Q2 Earnings

The good news was that the big pharmaceutical company beat earnings estimates. Merck & Co., Inc.

Keep Reading →

July 31 - News - Comments

AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY): 2 Keys to Success for This Diabetes Drug’s Second Chance

AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb Co. (NYSE:BMY) announced last week that they are making another attempt at U.S.

Keep Reading →

July 30 - News - Comments

Abbott Laboratories (ABT), Eli Lilly & Co. (LLY): Healthcare Stocks to Consider Buying

Note: This article has been amended to remove TRADJENTA as Eli Lilly & Co.

Keep Reading →

July 29 - News - Comments

Bristol Myers Squibb Co. (BMY), AstraZeneca plc (ADR) (AZN): Expanding P/E Saved This Pharma Investment

Three years ago, the company told investors not to worry. It had a plan to replace the $6 billion drug that lost patent protection last year.

Keep Reading →

July 28 - News - Comments

Eli Lilly & Co. (LLY), Seagate Technology PLC (STX), Reynolds American, Inc. (RAI): You Should Be Concerned With These 4 Post-Earnings Stocks

Earnings can change the outlook for a company, good or bad, and they can also validate an opinion that you already may have.

Keep Reading →

July 26 - News - Comments

Are Eli Lilly & Co. (LLY) Earnings Headed Down?

Eli Lilly & Co. (NYSE:LLY) will release its quarterly report tomorrow, and recent share-price declines show that investors are somewhat nervous about the company's prospects.

Keep Reading →

July 26 - News - Comments

Eli Lilly & Co. (LLY): What Does the Patent Cliff Mean for This Drugmaker?

For Eli Lilly & Co. (NYSE:LLY), history is repeating itself once again.

Keep Reading →

July 25 - News - Comments

AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY): The Diabetes Pipeline With a Clog

Big pharma placed its bets on a new class of diabetes drugs called SGLT2. Last year, buzz surrounded late-stage projects from Johnson and Johnson (NYSE:JNJ), Eli Lilly & Co.

Keep Reading →

July 22 - News - Comments

Alexion Pharmaceuticals, Inc. (ALXN), Eli Lilly & Co. (LLY): Five Drugmakers With a Lot on the Line

You may or may not have heard, but it's earnings season again.

Keep Reading →

July 22 - News - Comments

Three Key Takeaways From Johnson & Johnson (JNJ)’s Q2

Johnson & Johnson (NYSE:JNJ) reported its second quarter on Tuesday, and turned in some positive numbers. Revenue grew 8.5%, year-over-year, up to $17.9 billion.

Keep Reading →

July 19 - News - Comments

The Future of Sanofi SA (ADR) (SNY)’s Insulin Empire

Sanofi SA (ADR) (NYSE:SNY) appeared at the American Diabetes Association meeting last month, touting data for the new insulin U300 and a combo therapy involving its approved drugs...

Keep Reading →

July 18 - News - Comments

Eli Lilly & Co. (LLY), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The 3 Most Commonly Diagnosed Mental Disorders

The medical community certainly spends a lot of time and money researching treatments for cardiovascular disease and cancer.

Keep Reading →

July 15 - News - Comments

Could This Safe Play Help Eli Lilly & Co. (LLY)?

At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.

Keep Reading →

July 12 - News - Comments

Drug Deal Can Only Help VIVUS, Inc. (VVUS) So Much

VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.

Keep Reading →

July 10 - News - Comments

Could This Safe Play Help Eli Lilly & Co. (LLY)?

At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.

Keep Reading →

July 10 - News - Comments

Allergan, Inc. (AGN): A New Migraine Therapy That Can Address a Major Demand

One-fourth of all migraine patients suffer nasty side effects from the market's dominant migraine-fighting treatments.

Keep Reading →

July 9 - News - Comments

Spectrum Pharmaceuticals, Inc. (SPPI): Is This Biotech for Sale?

For the last five years, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) CEO Rajesh Shrotriya has always insisted that Spectrum Pharmaceuticals, Inc.

Keep Reading →

July 8 - News - Comments

GlaxoSmithKline plc (ADR) (GSK): Why You Should Buy This European Healthcare Company

Investors who buy stock in the major pharmaceutical companies likely do so because of several factors, including steady growth, modest valuations, and high dividend yields.

Keep Reading →

July 5 - News - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$293,447,417,000

David Einhorn

David Einhorn

Greenlight Capital

$1,491,303,000

George Soros

George Soros

Soros Fund Management

$5,416,602,000

Jim Simons

Jim Simons

Renaissance Technologies

$77,426,184,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$1,886,381,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$22,521,664,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$22,767,998,000

John Paulson

John Paulson

Paulson & Co

$3,510,256,000

David Tepper

David Tepper

Appaloosa Management LP

$4,198,712,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$6,160,740,000

Insider Monkey Small Cap Strategy
JulJanJulJanJulJanJulJan0%50%100%150%Return %Monthly Newsletter StrategyS&P 500
Most Read Posts
Dump Your Hedge Funds and Buy This Stock
World’s Most Expensive Desserts
The 10 Best Selling Products Online
The 10 Best Selling Items on Etsy
The 12 Most Profitable Small Businesses
The 10 Best-Selling Video Games of All Time
Lists

10 Biggest Discount Store Companies in the World

10 Biggest Discount Store Companies in the World

10 Biggest Digital Currencies in the World

10 Biggest Digital Currencies in the World

5 Biggest Digital Currencies in the World

5 Biggest Digital Currencies in the World

10 Biggest SaaS Companies in Europe

10 Biggest SaaS Companies in Europe

14 Most Valuable Venture-Backed Companies in the World

14 Most Valuable Venture-Backed Companies in the World

15 Most Valuable Music Companies in the World

15 Most Valuable Music Companies in the World

15 Most Valuable Companies in Sweden

15 Most Valuable Companies in Sweden

15 Most Valuable Beverage Companies in the World

15 Most Valuable Beverage Companies in the World

Dow 30 Stocks Listed and Ranked By 2022 Hedge Fund Bullishness Index

Dow 30 Stocks Listed and Ranked By 2022 Hedge Fund Bullishness Index

15 Dow Stocks Listed and Ranked By 2022 Hedge Fund Bullishness Index

15 Dow Stocks Listed and Ranked By 2022 Hedge Fund Bullishness Index

10 Biggest Utility Companies in the World

10 Biggest Utility Companies in the World

Crypto Crash: 10 Biggest Losers

Crypto Crash: 10 Biggest Losers

10 African Companies To Invest In Now

10 African Companies To Invest In Now

10 Biggest Hospital Companies in the World

10 Biggest Hospital Companies in the World

10 Biggest Education Companies in the World

10 Biggest Education Companies in the World

10 Biggest Online Streaming Companies in the World

10 Biggest Online Streaming Companies in the World

15 Most Valuable E-Commerce Companies in the World

15 Most Valuable E-Commerce Companies in the World

15 Most Valuable Software Companies in the World

15 Most Valuable Software Companies in the World

15 Most Valuable Platform Companies in the World

15 Most Valuable Platform Companies in the World

10 Biggest Crypto Companies in the World

10 Biggest Crypto Companies in the World

11 Best Augmented Reality Stocks to Invest In

11 Best Augmented Reality Stocks to Invest In

10 Best Plant Based Companies to Invest In

10 Best Plant Based Companies to Invest In

10 Best Tech Stocks to Buy For The Long Term

10 Best Tech Stocks to Buy For The Long Term

Naval Ravikant's Latest Investment Portfolio: 10 Companies to Watch

Naval Ravikant's Latest Investment Portfolio: 10 Companies to Watch

13 Most Ambitious Metaverse Companies in the World

13 Most Ambitious Metaverse Companies in the World

10 Most Profitable Biotech Companies in the World

10 Most Profitable Biotech Companies in the World

5 Most Profitable Biotech Companies in the World

5 Most Profitable Biotech Companies in the World

10 Cryptocurrencies Millionaires Love

10 Cryptocurrencies Millionaires Love

5 Largest Chip Producers In The World

5 Largest Chip Producers In The World

12 Largest Chip Producers In The World

12 Largest Chip Producers In The World

12 Biggest Agriculture Companies in the World

12 Biggest Agriculture Companies in the World

10 Cryptocurrencies To Buy and Hold for the Next 10 Years

10 Cryptocurrencies To Buy and Hold for the Next 10 Years

5 Biggest Green Energy Companies in the World

5 Biggest Green Energy Companies in the World

15 Most Valuable Real Estate Companies in the World

15 Most Valuable Real Estate Companies in the World

15 Most Valuable Korean Companies in the World

15 Most Valuable Korean Companies in the World

15 Most Valuable UK Companies in the World

15 Most Valuable UK Companies in the World

15 Most Valuable Japanese Companies in the World

15 Most Valuable Japanese Companies in the World

15 Most Valuable Beer Companies in the World

15 Most Valuable Beer Companies in the World

15 Most Valuable German Companies

15 Most Valuable German Companies

5 Most Valuable German Companies

5 Most Valuable German Companies

15 Most Valuable Government-Owned Companies in the World

15 Most Valuable Government-Owned Companies in the World

5 Most Valuable Government-Owned Companies in the World

5 Most Valuable Government-Owned Companies in the World

10 3D Printing Companies to Watch in 2022

10 3D Printing Companies to Watch in 2022

25 Safest Countries in the World

25 Safest Countries in the World

5 Safest Countries in the World

5 Safest Countries in the World

25 Most Aggressive Dog Breeds in America

25 Most Aggressive Dog Breeds in America

25 Most Popular Dog Breeds in the World

25 Most Popular Dog Breeds in the World

50 Things to Do When Bored

50 Things to Do When Bored

15 Most Valuable New Zealand Companies in the World

15 Most Valuable New Zealand Companies in the World

Top 15 Most Valuable Italian Companies

Top 15 Most Valuable Italian Companies
Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use CCPA - Do Not Sell My Information. ©2022 Koala Guide LLC.